IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,071,580 | -47.6% | 348,200 | -39.4% | 0.73% | -39.5% |
| Q2 2023 | $34,477,000 | -9.4% | 575,000 | -25.3% | 1.20% | -4.7% |
| Q1 2023 | $38,058,912 | -42.2% | 769,800 | -33.3% | 1.26% | -11.5% |
| Q4 2022 | $65,858,780 | -32.5% | 1,154,000 | -44.5% | 1.43% | -28.1% |
| Q3 2022 | $97,593,000 | +93.8% | 2,079,100 | +54.0% | 1.98% | +71.6% |
| Q2 2022 | $50,369,000 | +23.5% | 1,350,000 | -1.0% | 1.16% | +36.2% |
| Q1 2022 | $40,778,000 | -3.2% | 1,363,800 | +10.9% | 0.85% | -4.9% |
| Q4 2021 | $42,115,000 | +3.7% | 1,230,000 | +12.3% | 0.89% | -0.8% |
| Q3 2021 | $40,614,000 | +73.1% | 1,095,600 | +82.3% | 0.90% | +42.0% |
| Q2 2021 | $23,469,000 | +0.2% | 601,000 | +9.3% | 0.63% | -2.0% |
| Q1 2021 | $23,414,000 | – | 550,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |